Abstract
Natural history of hemifacial spasm (HFS) is not well documented yet. HFS usually starts from the orbicularis oculi muscle and gradually spreads to other muscles associated with facial expressions. Since HFS rarely improves spontaneously, it has been agreed that most patients need to be treated. According to our studies, even though symptoms sometimes improved, most patients became worse over time. Although the symptoms improve, appropriate treatment will be necessary for well-selected patients because such situations do not often occur and quality of life is impaired while the symptoms are present.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barker FG 2nd, Jannetta PJ, Bissonette DJ, Shields PT, Larkins MV, Jho HD. Microvascular decompression for hemifacial spasm. J Neurosurg. 1995;82:201–10.
Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998;21:1740–7.
Mauriello JA Jr, Leone T, Dhillon S, Pakeman B, Mostafavi R, Yepez MC. Treatment choices of 119 patients with hemifacial spasm over 11 years. Clin Neurol Neurosurg. 1996;98:213–6.
Lee JA, Jo KW, Kong DS, Park K. Using the new clinical grading scale for quantification of the severity of Hemifacial spasm: correlations with a quality of life scale. Stereotact Funct Neurosurg. 2012;90:16–9.
Hyun SJ, Kong DS, Park K. Microvascular decompression for treating hemifacial spasm: lessons learned from a prospective study of 1,174 operations. Neurosurg Rev. 2010;33:325–34. discussion 334
Lee JA, Kim KH, Park K. Natural history of untreated Hemifacial spasm: a study of 104 consecutive patients over 5 years. Stereotact Funct Neurosurg. 2017;95:21–5.
Conte A, Falla M, Diana MC, Bologna M, Suppa A, Fabbrini A, Colosimo C, Berardelli A, Fabbrini G. Spread of muscle spasms in Hemifacial spasm. Mov Disord Clin Pract. 2014;2(1):53–5.
Defazio G, Abbruzzese G, Girlanda P, Vacca L, Curra A, De Salvia R, Marchese R, Raineri R, Roselli F, Livrea P, Berardelli A. Botulinum toxin a treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol. 2002;59:418–20.
Mauriello JA, Aljian J. Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years. Br J Ophthalmol. 1991;75:737–9.
Sanders DB. Ephaptic transmission in hemifacial spasm: a single-fiber EMG study. Muscle Nerve. 1989;12:690–4.
Valls-Solé J. Electrodiagnostic studies of the facial nerve in peripheral facial palsy and hemifacial spasm. Muscle Nerve. 2007;36:14–20.
Kuroki A, Møller AR. Facial nerve demyelination and vascular compression are both needed to induce facial hyperactivity: a study in rats. Acta Neurochir. 1994;126:149–57.
Møller AR, Jannetta PJ. On the origin of synkinesis in hemifacial spasm: results of intracranial recordings. J Neurosurg. 1984;61:569–76.
Tunç T, Cavdar L, Karadag YS, Okuyucu E, Coskun O, Inan LE. Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment. J Clin Neurosci. 2008;15:253–6.
Ozel-Kizil ET, Akbostanci MC, Ozguven HD, Atbasoglu EC. Secondary social anxiety in hyperkinesias. Mov Disord. 2008;23(5):641–5.
Mula M, Strigaro G, Marotta AE, Ruggerone S, Tribolo A, Monaco R, Cantello F. Obsessive-compulsive-spectrum symptoms in patients with focal dystonia, hemifacial spasm, and healthy subjects. J Neuropsychiatry Clin Neurosci. 2012;24(1):81–6.
Perozzo P, Salatino A, Cerrato P, Ricci R. Sexual Well-being in patients with blepharospasm, spasmodic torticollis, and hemifacial spasm: a pilot study. Front Psychol. 2016;7:1492.
Tan EK, Lum SY, Fook-Chong S, Chan LL, Gabriel C, Lim L. Behind the facial twitch: depressive symptoms in hemifacial spasm. Parkinsonism Relat Disord. 2005;11(4):241–5.
Peeraully T, Tan SF, Fook-Chong SM, Prakash KM, Tan EK. Headache in hemifacial spasm patients. Acta Neurol Scand. 2013;127(5):e24–7.
Cheng J, Lei D, Hui X, Zhang H. Improvement of quality of life in patients with Hemifacial spasm after microvascular decompression: a prospective study. World Neurosurg. 2017;107:549–53.
Tan EK, Fook-Chong S, Lum SY. Case-control study of anxiety symptoms in hemifacial spasm. Mov Disord. 2006;21(12):2145–9.
Tan EK, Fook-Chong S, Lum SY, Lim E. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30). J Neurol Sci. 2004;219(1–2):151–5.
Setthawatcharawanich S, Sathirapanya P, Limapichat K, Phabphal K. Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin. Qual Life Res. 2011;20(9):1519–23. https://doi.org/10.1007/s11136-011-9890-y.
Kongsengdao S, Kritalukkul SJ. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study. Med Assoc Thai. 2012;95(Suppl 3):S48–54.
Weiss D, Sturm J, Hieber L, Börtlein A, Mayr I, Appy M, Kühnler B, Buchthal J, Dippon C, Arnold G, Wächter T. Health-related quality of life outcomes from botulinum toxin treatment in hemifacial spasm. Ther Adv Neurol Disord. 2017;10(4):211–6. https://doi.org/10.1177/1756285616682676. Epub 2017 Feb 1
Yuksel B, Genc F, Yaman A, Goksu EO, Ak PD, Gomceli YB. Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment. Acta Neurol Belg. 2019;119(1):55–60. https://doi.org/10.1007/s13760-018-1018-5. Epub 2018 Sep 3
Kim YG, Jung NY, Kim M, Chang WS, Jung HH, Chang JW. Benefits of microvascular decompression on social anxiety disorder and health-related quality of life in patients with hemifacial spasm. Acta Neurochir. 2016;158(7):1397–404.
Montava M, Rossi V, CurtoFais CL, Mancini J, Lavieille JP. Long-term surgical results in microvascular decompression for hemifacial spasm: efficacy, morbidity and quality of life. Acta Otorhinolaryngol Ital. 2016;36(3):220–7.
Lawrence JD, Frederickson AM, Chang YF, Weiss PM, Gerszten PC, Sekula RF Jr. An investigation into quality of life improvement in patients undergoing microvascular decompression for hemifacial spasm. J Neurosurg. 2017;10:1–9.
Ray DK, Bahgat D, McCartney S, Burchiel KJ. Surgical outcome and improvement in quality of life after microvascular decompression for hemifacial spasms: a case series assessment using a validated disease-specific scale. Stereotact Funct Neurosurg. 2010;88(6):383–9.
Shibahashi K, Morita A, Kimura T. Surgical results of microvascular decompression procedures and patient’s postoperative quality of life: review of 139 cases. Neurol Med Chir. 2013;53(6):360–4.
Lee JA, Kong DS, Lee S, Park SK, Park K. Clinical outcome after microvascular decompression according to the progression rates of hemifacial spasm. World Neurosurg. 2020;134:e985-e990. https://doi.org/10.1016/j.wneu.2019.11.052. Epub 2019 Nov 14.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Lee, JA., Park, K. (2020). Natural History of Hemifacial Spasm. In: Park, K., Park, J.S. (eds) Hemifacial Spasm. Springer, Singapore. https://doi.org/10.1007/978-981-15-5417-9_2
Download citation
DOI: https://doi.org/10.1007/978-981-15-5417-9_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-5416-2
Online ISBN: 978-981-15-5417-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)